280 related articles for article (PubMed ID: 33042585)
21. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.
Kula AJ; Hanberg JS; Wilson FP; Brisco MA; Bellumkonda L; Jacoby D; Coca SG; Parikh CR; Tang WHW; Testani JM
Circ Heart Fail; 2016 Jan; 9(1):e002333. PubMed ID: 26699390
[TBL] [Abstract][Full Text] [Related]
22. The prognostic role of different renal function phenotypes in patients with acute heart failure.
Palazzuoli A; Ruocco G; Pellicori P; Incampo E; Di Tommaso C; Favilli R; Evangelista I; Nuti R; Testani JM
Int J Cardiol; 2019 Feb; 276():198-203. PubMed ID: 30503187
[TBL] [Abstract][Full Text] [Related]
23. Renal dysfunction in acute heart failure.
Han SW; Ryu KH
Korean Circ J; 2011 Oct; 41(10):565-74. PubMed ID: 22125554
[TBL] [Abstract][Full Text] [Related]
24. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
[TBL] [Abstract][Full Text] [Related]
25. Fluid removal in acute heart failure: diuretics versus devices.
Krishnamoorthy A; Felker GM
Curr Opin Crit Care; 2014 Oct; 20(5):478-83. PubMed ID: 25111680
[TBL] [Abstract][Full Text] [Related]
26. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
[TBL] [Abstract][Full Text] [Related]
27. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
[TBL] [Abstract][Full Text] [Related]
28. Loop diuretics in chronic heart failure: how to manage congestion?
Simonavičius J; Knackstedt C; Brunner-La Rocca HP
Heart Fail Rev; 2019 Jan; 24(1):17-30. PubMed ID: 30194516
[TBL] [Abstract][Full Text] [Related]
29. The Congestion "Pandemic" in Acute Heart Failure Patients.
Mocan D; Lala RI; Puschita M; Pilat L; Darabantiu DA; Pop-Moldovan A
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790913
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
[TBL] [Abstract][Full Text] [Related]
31. Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements.
Ruocco G; Feola M; Nuti R; Luschi L; Evangelista I; Palazzuoli A
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31684094
[TBL] [Abstract][Full Text] [Related]
32. Treatment Approaches to Congestion Relief in Acute Decompensated HF: Insights After DOSE-AHF and CARRESS-HF.
Shakar SF; Lindenfeld J
Curr Treat Options Cardiovasc Med; 2014 Aug; 16(8):330. PubMed ID: 25063583
[TBL] [Abstract][Full Text] [Related]
33. Treatment strategies for diuretic resistance in patients with heart failure.
Horiuchi Y; Wettersten N
J Cardiol; 2024 Jun; ():. PubMed ID: 38914279
[TBL] [Abstract][Full Text] [Related]
34. Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance.
Liu C; Liu K
J Card Fail; 2014 Sep; 20(9):625-9. PubMed ID: 24969700
[TBL] [Abstract][Full Text] [Related]
35. Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF.
Grodin JL; Lala A; Stevens SR; DeVore AD; Cooper LB; AbouEzzeddine OF; Mentz RJ; Groarke JD; Joyce E; Rosenthal JL; Vader JM; Tang WH
J Card Fail; 2016 Nov; 22(11):884-890. PubMed ID: 26844764
[TBL] [Abstract][Full Text] [Related]
36. Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment - Results From the K-STAR Study.
Inomata T; Ikeda Y; Kida K; Shibagaki Y; Sato N; Kumagai Y; Shinagawa H; Ako J; Izumi T;
Circ J; 2017 Dec; 82(1):159-167. PubMed ID: 28835586
[TBL] [Abstract][Full Text] [Related]
37. Diuretic Resistance in Heart Failure.
Gupta R; Testani J; Collins S
Curr Heart Fail Rep; 2019 Apr; 16(2):57-66. PubMed ID: 30762178
[TBL] [Abstract][Full Text] [Related]
38. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.
Ter Maaten JM; Damman K; Hanberg JS; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; Cleland JG; Bloomfield DM; Hillege HL; van Veldhuisen DJ; Voors AA; Testani JM
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507112
[TBL] [Abstract][Full Text] [Related]
39. Congestive heart failure and decongestion ability of two different treatments: continuous renal replacement and diuretic therapy: experience of a cardiac step down unit.
Giglioli C; Spini V; Landi D; Chiostri M; Romano SM; Calabretta R; Gensini GF; Cecchi E
Acta Cardiol; 2013 Aug; 68(4):355-64. PubMed ID: 24187761
[TBL] [Abstract][Full Text] [Related]
40. Acute heart failure: acute cardiorenal syndrome and role of aggressive decongestion.
Hanna EB; Hanna Deschamps E
Clin Cardiol; 2014 Dec; 37(12):773-8. PubMed ID: 25403797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
